There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 500 μg |
| Product Overview | Recombinant human APOC3 protein (NP_000031.1) is produced in Glycoengineered Mannose-5 Pichia pastoris. This expression system is used for the production of glycoproteins and antibodies with a mannose-5 structure at N-linked sites. |
| Source | Glycoengineered Mannose-5 Pichia pastoris |
| Species | Human |
| Tag | His-tag, FC-tag |
| Purity | >90%, determined by SDS-PAGE. |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | APOC3 |
| Full Name | Apolipoprotein C-III |
| Gene ID | 345 |
| Uniprot ID | P02656 |
| Accession Number | NP_000031.1 |
| Background | Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia. |
| Alternate Names | Apo-CIII; ApoC-III; Apolipoprotein C3; APOC3 |